The biotech sector gained widespread attention in 2020 ... reaching over $830.31 billion. Asia Pacific had a revenue ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

Amidst global market fluctuations and economic uncertainty, small-cap stocks in Asia present a unique opportunity for investors seeking growth potential. In this environment, identifying stocks with ...

and nowhere is this more apparent than in the biopharmaceutical sector. While traditional biotech hubs in the West contend with policy volatility and funding constraints, countries in the Asia ...

Samsung Biologics, the biopharmaceutical arm of Samsung Group, said on May 26 it had secured two contract manufacturing deals ...

Find out how efficient Asia’s healthcare system is with Prof Himanshu Rai at the Indian Institute of Management Indore ...

Asia Pacific is estimated to grow at the fastest rate during ... is anticipated to grow to $300 billion by 2030. Top Factors in Indian Biotechnology Industry Being one of the most lucrative ...

By promoting biotechnology as an interdisciplinary field ... and conferences to engage and empower scientists and industry professionals in Asia. Notable recent events of AFOB include, webinar by the ...

“We welcomed more than 3,000 attendees, including 1,026 investors and 86 media representatives this year in a testament to the resilience and ingenuity of the biotech sector,” said Sara Jane ...

money is also flowing toward research activities at universities to address a shortage of skilled workers in the sector. In order to facilitate the market launch of biotech meat, several Asian ...

As global markets experience volatility, with small- and mid-cap indexes facing significant declines amid renewed tariff threats and rising Treasury yields, the Asian tech sector continues to draw ...